| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_MTO1_0005600 | Intron-Exon-Intron | chr6:74196321-74202075 | chr6:73486598-73492352 | 283 nt | 0.4664 |
| hsa_MTO1_0005700 | Intron-Intron | chr6:74201077-74201610 | chr6:73491354-73491887 | 534 nt | 0.3951 |
| hsa_MTO1_0005800 | Exon-Exon | chr6:74201957-74207619 | chr6:73492234-73497896 | 280 nt | 0.4143 |
| hsa_MTO1_0005900 | Exon-Exon | chr6:74201957-74211013 | chr6:73492234-73501290 | 119 nt | 0.4202 |
| hsa_MTO1_0006000 | Exon-Exon | chr6:74201957-74213411 | chr6:73492234-73503688 | 280 nt | 0.4143 |
| hsa_MTO1_0006100 | Intron-Intron | chr6:74202076-74207425 | chr6:73492353-73497702 | 250 nt | 0.2400 |
| hsa_chr6_0619700 | Intergenic-Intergenic | chr6:74205346-74205502 | chr6:73495623-73495779 | 157 nt | 0.3185 |
| hsa_MTO1_0006200 | Exon-Exon | chr6:74210297-74211521 | chr6:73500574-73501798 | 1225 nt | 0.3698 |
| hsa_RP11-505P4.6_0000100 | Intergenic-Intron | chr6:74183624-74202221 | chr6:73473901-73492498 | 250 nt | 0.3480 |
| hsa_RP11-505P4.6_0000200 | Intergenic-Exon-Intergenic | chr6:74189494-74210808 | chr6:73479771-73501085 | 1685 nt | 0.4267 |
A review consolidating existing research indicates that the circMTO1 functions as a tumor suppressor in hepatocellular carcinoma [Lee et al. DOI:10.1016/j.biopha.2018.12.052] and sponges miR-630 to reverse temozolomide chemoresistance in glioblastoma [Mehta et al. DOI:10.1016/j.pneurobio.2020.101746].